Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (75)
Cancellation by sponsor (43)
Prescription medicine registration (6)
Designation or determination (4)
Australian Public Assessment Report (AusPAR) (1)
Prescription medicine evaluation (1)

Date

2024 (1)
2023 (32)
2022 (10)
2021 (11)
2020 (7)
2019 (3)
2018 (3)
2017 (10)
2016 (4)
2015 (11)
2014 (2)
2013 (2)
2012 (5)
2009 (2)
2008 (1)
2005 (2)
2004 (2)
2001 (2)
2000 (2)
1998 (3)
1997 (3)
1996 (1)
1994 (2)
1993 (1)
1992 (1)
1991 (7)

Results for "[search-keyword]"

Search

Sponsor content

130 result(s) found, displaying 51 to 60

TREXJECT IN methotrexate (as sodium) 15mg/0.30mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 12.5mg/0.25mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 10mg/0.20mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
TREXJECT IN methotrexate (as sodium) 7.5mg/0.15mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
MERCAPTOPURINE-LINK mercaptopurine monohydrate 50 mg tablet bottle (306940)

14 June 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MERCAPTOPURINE-LINK mercaptopurine monohydrate 50 mg tablet bottle.
COCOIS ointment tube Cancelled under Section 30(1)(c) of the Act

11 November 2020

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
SALACT Medicated Face Wash salicylic acid 20mg/mL lotion bottle Cancelled under Section 30(1)(c) of the Act

11 November 2020

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
MICANOL dithranol 1% cream tube Cancelled under Section 30(1)(c) of the Act

11 November 2020

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
OXALIPLATIN KABI PFI oxaliplatin 50 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

11 November 2020

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
OXALIPLATIN KABI PFI oxaliplatin 100 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

11 November 2020

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.